日本人小児肺動脈性肺高血圧症患者に対するepoprostenol新規持続静注製剤の治験結果：有効性，安全性及び忍容性の検討

佐地 勉; 山田 修; 土井 庄三郎; 山岸 敬幸; 八田 基稔; 横山 由斉

doi:10.9794/jspccs.34.30

Pediatric Cardiology and Cardiac Surgery

Online ISSN : 2187-2988
Print ISSN : 0911-1794
ISSN-L : 0911-1794

Original

Results of a Clinical Trial to Determine the Efficacy, Safety, and Tolerability of Intravenous Drip Infusion Therapy of a New Epoprostenol Formulation in Japanese Children with Pulmonary Arterial Hypertension

Tsutomu Saji, Osamu Yamada, Shozaburo Doi, Hiroyuki Yamagishi, Motonori Hatta, Yoshinari Yokoyama

Author information

Keywords: pulmonary arterial hypertension, epoprostenol, children, efficacy, safety

JOURNAL FREE ACCESS

2018 Volume 34 Issue 1 Pages 30-38

DOI https://doi.org/10.9794/jspccs.34.30

Details

Abstract

[in Japanese]

Content from these authors

Favorites & Alerts

Corresponding author

Register with J-STAGE for free!